Director Yemin sells 84,650 Delek (NYSE: DK) shares under plan

Rhea-AI Filing Summary

Delek US Holdings director Ezra Uzi Yemin reported open-market sales of Delek common stock. On March 4, 2026, he sold 18,139 directly owned shares at a weighted average price of $43.17 per share, leaving 240,281 shares held directly.

On the same date, 66,511 shares were sold indirectly through Yemin Investments, LP at the same weighted average price, with 613,145 shares remaining held indirectly. The filing notes these transactions were made under a Rule 10b5-1 trading plan adopted on December 3, 2025, using multiple trades between $43.00 and $43.57 per share.

Insider Trade Summary

Net Seller: 84,650 shares ($3,654,341)

Net Sell 2 txns

Insider Yemin Ezra Uzi

Role Director

Sold 84,650 shs ($3.65M)

Type	Security	Shares	Price	Value
Sale	Common Stock	18,139	$43.17	$783K
Sale	Common Stock	66,511	$43.17	$2.87M

Holdings After Transaction: Common Stock — 240,281 shares (Direct); Common Stock — 613,145 shares (Indirect, By Yemin Investments, LP)

Footnotes (1)

1. This transaction was made pursuant to a 10b5-1 plan adopted on December 3, 2025, and is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The price reflects the weighted average sale price of multiple transactions ranging from a low sale price of $43.00 per share to a high sale price of $43.57 per share. Upon the written request of the SEC, the Issuer or a security holder of the Issuer, the reporting person agrees to provide the number of shares sold at each sale price.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Yemin Ezra Uzi

(Last) (First) (Middle)

310 SEVEN SPRINGS WAY

SUITE 500

(Street)

BRENTWOOD TN 37027

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Delek US Holdings, Inc. [ DK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/04/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/04/2026		S(1)		18,139	D	$43.17(2)	240,281	D
Common Stock	03/04/2026		S(1)		66,511	D	$43.17(2)	613,145	I	By Yemin Investments, LP

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This transaction was made pursuant to a 10b5-1 plan adopted on December 3, 2025, and is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

2. The price reflects the weighted average sale price of multiple transactions ranging from a low sale price of $43.00 per share to a high sale price of $43.57 per share. Upon the written request of the SEC, the Issuer or a security holder of the Issuer, the reporting person agrees to provide the number of shares sold at each sale price.

Remarks:

	/s/ Misty Lavender, Attorney in Fact	03/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Delek US (DK) director Ezra Uzi Yemin report?

Ezra Uzi Yemin reported open-market sales totaling 84,650 Delek US common shares on March 4, 2026. The transactions combined a direct sale of 18,139 shares and an indirect sale of 66,511 shares through Yemin Investments, LP.

At what price did Ezra Uzi Yemin sell Delek US (DK) shares?

The sales used a weighted average price of $43.17 per share. Individual trades occurred across multiple transactions, with sale prices ranging from $43.00 to $43.57 per share, according to the pricing footnote in the disclosure.

How many Delek US (DK) shares does Ezra Uzi Yemin hold after the reported sales?

After the sales, Ezra Uzi Yemin holds 240,281 Delek US shares directly and 613,145 shares indirectly through Yemin Investments, LP. These post-transaction balances are stated in the ownership columns of the reported transactions.

Were Ezra Uzi Yemin’s Delek US (DK) share sales under a 10b5-1 trading plan?

Yes. The filing states the transactions were made under a Rule 10b5-1 trading plan adopted on December 3, 2025. The plan is described as intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Which entity handled the indirect sale of Delek US (DK) shares for Ezra Uzi Yemin?

The indirect sale of 66,511 Delek US shares was reported as held “By Yemin Investments, LP”. This entity is listed in the nature of ownership field, indicating the shares are owned indirectly through that limited partnership.

How many Delek US (DK) shares did Ezra Uzi Yemin sell in total on March 4, 2026?

In total, the reported transactions show 84,650 Delek US common shares sold on March 4, 2026. This consists of 18,139 shares sold directly and 66,511 shares sold indirectly via Yemin Investments, LP.